Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.
- Resource Type
- Article
- Source
- Cell Discovery; 4/21/2022, Vol. 8 Issue 1, p1-16, 16p
- Subject
SARS-CoV-2 BISPECIFIC antibodies SARS-CoV-2 Omicron variant COVID-19 IMMUNOGLOBULINS SARS-CoV-2 Delta variant BINDING site assay - Language
- ISSN
- 20565968